NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

9567	Companies
189136	Keywords
120831	Articles
100916	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 02/12/2025 at 22:20, 10 months 9 days ago

Nanobiotix: Details on Voting Rights and Shares in January 2025

Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 02/12/2025 at 22:15, 10 months 9 days ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Communiqué mensuel de Nanobiotix sur les droits de vote et actions. Informations financières conformes à la règlementation des marchés financiers. Nanobiotix, société de biotechnologie, cotée à Euronext Paris et Nasdaq, développe des traitements innovants

Euronext Paris Biotechnologie Nasdaq NANOBIOTIX Traitements Innovants
PRESS RELEASE

published on 02/12/2025 at 22:15, 10 months 9 days ago

Voting Rights and Shares Capital of the Company
Nanobiotix announces voting rights and shares capital details. Company listed on Euronext Paris and Nasdaq. Focus on disruptive therapeutic approaches

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 12/17/2024 at 22:20, 1 year ago

NANOBIOTIX Prépare son Événement Virtuel Révolutionnaire

Cancer NANOBIOTIX Technologie Nanothérapeutique Curadigm Médicaments Intraveineux
BRIEF

published on 12/17/2024 at 22:20, 1 year ago

NANOBIOTIX Prepares its Revolutionary Virtual Event

Cancer NANOBIOTIX Curadigm Nanotherapeutic Technology Intravenous Medications
PRESS RELEASE

published on 12/17/2024 at 22:15, 1 year ago

NANOBIOTIX présentera sa vision pour révolutionner la conception et le développement de médicaments à travers sa prochaine plateforme nanothérapeutique le 19 décembre 2024
Nanobiotix présente sa plateforme nanothérapeutique lors d'un événement virtuel le 19/12 à 15h00 CET / 9h00 ET pour améliorer les traitements pour les patients atteints de cancer

Innovation Cancer Événement Virtuel NANOBIOTIX Nanothérapeutique
PRESS RELEASE

published on 12/17/2024 at 22:15, 1 year ago

NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Nanobiotix announces virtual event 'Accelerating the Future of Nanotherapeutics' on December 19, 2024, showcasing Curadigm Nanoprimer Platform for drug development

Virtual Event NANOBIOTIX Curadigm Nanotherapeutics Nanoprimer
BRIEF

published on 12/09/2024 at 22:20, 1 year ago

Nanobiotix conclut avec succès une étude de phase 1 sur le cancer du pancréas

FDA Étude De Phase 1 Cancer Du Pancréas Chimiothérapie Radiothérapie
BRIEF

published on 12/09/2024 at 22:20, 1 year ago

Nanobiotix successfully completes phase 1 study in pancreatic cancer

FDA Pancreatic Cancer Chemotherapy Phase 1 Study Radiotherapy
PRESS RELEASE

published on 12/09/2024 at 22:15, 1 year ago

NANOBIOTIX annonce l’achèvement de l’étude de phase 1 avec NBTXR3 (JNJ-1900) dans le cancer du pancréas
Nanobiotix annonce l'achèvement de l'étude de Phase 1 avec NBTXR3 dans le cancer du pancréas, avec des résultats encourageants. Un essai randomisé est prévu. Plus d'informations sur www.nanobiotix.com

Étude De Phase 1 Cancer Du Pancréas NANOBIOTIX NBTXR3 Essai Randomisé

Accesswire

Published on 12/22/2025 at 15:00, 4 hours 23 minutes ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares
Published on 12/22/2025 at 14:40, 4 hours 43 minutes ago

Namibia Critical Metals Inc. Receives Proceeds of $1,154,762 from Exercise of Warrants
Published on 12/22/2025 at 14:30, 4 hours 53 minutes ago

Prospect Ridge Updates Diamond Drill Program at 100% Owned Camelot Copper-Gold Project in B.C.'S Cariboo Mining District
Published on 12/22/2025 at 14:00, 5 hours 23 minutes ago

Rio Grande Resources Completes 2025 Field Program and Advances Drill Targeting at the Winston Gold-Silver Project
Published on 12/22/2025 at 14:00, 5 hours 23 minutes ago

PPX Mining Appoints Ernest Mast as President and CEO and Announces Stock Option Grants

View all ACCESSWIRE

EQS Group

Published on 12/22/2025 at 19:00, 23 minutes ago

PATRIMOINE ET COMMERCE: Déclarations des transactions sur actions propres (hors contrat de liquidité) réalisées le 19 décembre 2025
Published on 12/22/2025 at 18:51, 32 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 12/22/2025 at 18:20, 1 hour 3 minutes ago

CGTN: How China drives high-quality development through technological innovation
Published on 12/22/2025 at 18:14, 1 hour 9 minutes ago

Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
Published on 12/22/2025 at 18:00, 1 hour 23 minutes ago

ENOGIA: ENOGIA secures €2 million in financing from Vatel Capital, which can be increased to €3 million - Transaction to support the Turbo 2028 plan

Les Echos

Published on 12/22/2025 at 18:33, 50 minutes ago

ABEO SE RENFORCE ET OBTIENT UNE TRÈS LARGE MAJORITÉ DU CAPITAL DE VOGO AVEC 90,84% DÉTENUS À L’ISSUE DE L’OFFRE RÉOUVERTE
Published on 12/22/2025 at 18:05, 1 hour 18 minutes ago

Covivio - Treasury shares transactions between December 15th , 2025 and December 19th, 2025
Published on 12/22/2025 at 18:05, 1 hour 18 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 15 décembre au 19 décembre 2025
Published on 12/22/2025 at 17:45, 1 hour 38 minutes ago

Déclaration des transactions sur actions propres réalisées du 15 au 19 décembre 2025 dans le cadre du programme de rachat d’actions
Published on 12/22/2025 at 17:35, 1 hour 48 minutes ago

DECLARATION HEBDOMADAIRE D'OPERATIONS EFFECTUEES DU 15 AU 19 DECEMBRE 2025

View all LES ECHOS COMFI WIRE